3D diagnostic imaging services market seen reaching $426.48B by 2030

The Business Research Company says the 3D diagnostic imaging services market will grow from $289.49 billion in 2025 to $426.48 billion by 2030, driven by chronic disease growth, AI-enabled imaging and broader use of precision diagnostics. North America led the market in 2025, while the report points to oncology and cardiology as major growth areas.

Why it matters: - 3D diagnostic imaging is becoming more important as healthcare systems look for faster, more precise ways to detect and monitor disease. - The market’s projected expansion signals stronger demand for advanced imaging services, software and diagnostic infrastructure across hospitals and specialty centers. - Chronic disease management remains a major pressure point, making detailed imaging more valuable for treatment planning and follow-up.

What happened: - The Business Research Company projected the global 3D diagnostic imaging services market will rise from $289.49 billion in 2025 to $313.86 billion in 2026. - The report forecasts the market will reach $426.48 billion by 2030. - The forecast implies an 8.4% CAGR from 2025 to 2026 and an 8.0% CAGR through 2030. - North America held the largest market share in 2025. - Western Europe ranked second in 2025.

The details: - The report ties near-term growth to rising chronic disease prevalence, higher demand for precise diagnostic techniques, improved hospital imaging infrastructure, stronger awareness of early disease detection and continued use of MRI and CT systems. - The longer-term outlook is supported by AI-powered 3D imaging analysis, investment in advanced diagnostic technologies, growing demand for personalized and precision diagnostics and expansion in emerging economies. - Multimodal imaging integration is expected to accelerate technical progress in the market. - Key trends include greater use of 3D imaging for early disease detection, demand for higher-resolution imaging, preference for non-invasive procedures and growth in advanced diagnostic centers. - Oncology and cardiology are among the major clinical areas expected to adopt 3D imaging more widely. - The report defines 3D diagnostic imaging as optical imaging that creates a three-dimensional view inside the body for detailed examination of internal structures. - The technology supports diagnosis and treatment planning by helping clinicians identify signs of disease with greater clarity and precision.

Between the lines: - The market’s growth story is less about one single technology and more about the combination of disease burden, workflow needs and capital spending on better diagnostics. - AI and multimodal imaging point to a shift from basic image capture toward more integrated interpretation and decision support. - The chronic disease data cited in the report reinforces why imaging demand is likely to keep rising as aging populations need more monitoring.

What's next: - The report expects broader adoption of 3D imaging in early detection workflows and specialty care settings. - Growth in emerging markets could become a bigger driver as imaging services expand beyond mature healthcare systems. - The full report and sample materials are available through the company's website, including a free sample report and the full market report.